SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Valmie Resources Inc (OTCBB:VMRI) announced it achieved a major accomplishment as its “V-1 Drone prototype” successfully concluded its first flight. The unmanned aerial vehicle lifted off from the test location and thereafter the engineering team on the ground observed its progress and data stream. Gerald B. Hammack, the President and CEO said that he heartily congratulate the company’s development team for the V-1’s first flight. The management looks forward to launching best-in-class technology that will capture market share and increase shareholder value.

The assessment process

While in the air, Valmie’s crew conducted several evaluation procedures like testing the calibration of the controller, assessing handling features at a variety of speeds, and checking the statistics being analyzed by the installed data capturing system in flight.

Hammack further added that the highly awaited V-1 Drone has shown extraordinary performance and it marks the initiation of a rigorous flight test program. The coming phase of trials and test will be dedicated to evaluation of all operational systems and combining the proprietary AIMD Platform, which is in development stage.

The plans

Valmie intends to collaborate with “Monitoreo Especializado Agrícola de Jalisco S.A.” by offering its commercial drone technology for the firm’s crop monitoring activities in South and Central America. One of the company’s focus segments is agriculture. It is in the list of the most capable applications for UAV’s. The farm operators are looking for on-demand information on a frequent and continual basis.

The UAV technology that is already used in many parts of the world helps growers to efficiently monitor their fields. It also helps to manage crop development and mitigate crop stressors. V-1 Drone is being manufactured to be used with several imaging sensors. In last trading session, the stock price of VMRI dropped 2.87% to close the trading session at $3.08 on share volume of 96,191.

SHARE
Previous articleAxxess Pharma Inc (OTCMKTS:AXXE) Updates On Recent Accomplishments
Next articleOXIS International, Inc. (OTCMKTS:OXIS) Common Stock Resumes Trading On Euronext Paris
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg, Equities.com, Hacked.com, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.